Bookbuilding IPO | ₹93 Cr | Listed at BSE, NSE | Wed, Jun 22, 2005 - Tue, Jun 28, 2005
Nectar Lifesciences IPO is a book build issue of ₹92.88 crores. The issue is entirely a fresh issue of 0.39 crore shares of ₹92.88 crore.
Nectar Lifesciences IPO bidding started from Jun 22, 2005 and ended on Jun 28, 2005.
Nectar Lifesciences IPO is set final issue price at ₹240 per share.
ICICI Securities Ltd. is the book running lead manager and Kfin Technologies Ltd. is the registrar of the issue.
Refer to Nectar Lifesciences IPO RHP for detailed Information.
IPO Open
Wed, Jun 22, 2005
IPO Close
Tue, Jun 28, 2005
Issue Price
₹240 per share
Market Cap (Pre-IPO)
To be declared
| IPO Date | 22 to 28 Jun, 2005 |
| Listed on | Mon, Jul 18, 2005 |
| Face Value | ₹10 per share |
| Price Band | ₹200 to ₹240 |
| Issue Price | ₹240 per share |
| Lot Size | |
| Sale Type | Fresh capital only |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE, NSE |
| Total Issue Size | 38,70,000 shares (agg. up to ₹93 Cr) |
| Fresh Issue | 38,70,000 shares (agg. up to ₹93 Cr) |
| Share Holding Pre Issue | 1,10,16,667 shares |
| Share Holding Post Issue | 1,48,86,667 shares |
| BSE Script Code / NSE Symbol | 532649 / NECLIFE |
| ISIN | INE023H01027 |
Nectar Lifesciences IPO comprises a total issue size of 38,70,000 shares. Out of which, 19,35,000 (50.00%) are allocated to QIB, 5,80,500 (15.00%) allocated to NII 13,54,500 (35.00%) allocated to RII.
| Investor Category | Shares Offered | % of Total Issue |
|---|---|---|
| QIB Shares Offered | 19,35,000 | 50.00% |
| NII (HNI) Shares Offered | 5,80,500 | 15.00% |
| Retail Shares Offered | 13,54,500 | 35.00% |
| Total Shares Offered | 38,70,000 | 100.00% |
Nectar Lifesciences Limited is a pharmaceutical company engaged in the manufacturing and marketing of active pharmaceutical ingredients (APIs), formulations, and menthol-based products. The company has established itself as a key player in the global pharma supply chain, exporting to multiple countries across regulated and semi-regulated markets.
The company’s product portfolio includes APIs such as cephalosporins, formulations including tablets, capsules, and dry syrups, as well as menthol and mint derivatives.
Nectar Lifesciences operates integrated manufacturing facilities, enabling it to control quality and costs efficiently. It caters to both domestic and international pharmaceutical companies, with a strong presence in export markets.
With manufacturing units located in Punjab and Himachal Pradesh, Nectar Lifesciences focuses on research-driven growth, regulatory compliance, and expanding its product offerings. The company aims to strengthen its position in high-value pharmaceutical segments while maintaining consistent quality and global standards.
| Period Ended | 31 Mar 2005 | 31 Mar 2004 | 31 Mar 2003 |
|---|---|---|---|
| Assets | 252.50 | 168.90 | 127.30 |
| Profit After Tax | 22.60 | 10.80 | 7.80 |
| NET Worth | 72.10 | 52.10 | 42.40 |
| Amount in ₹ Crore | |||
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Formulation Plant at Baddi | 30.00 |
| 2 | Sterile Cephalosporin facility (Unit II) | 30.00 |
| 3 | Research & Development facility and Corporate Quality Control Centre (Unit II) | 25.00 |
| 4 | Issue Expenses | 5.00 |
| Total | 90.00 |
| KPI | Mar 31, 2004 |
|---|---|
| RoNW | 31.3% |
| Pre IPO | Post IPO | |
|---|---|---|
| Promoter Holding | 89.08% | 65.93% |
The Nectar Lifesciences IPO IPO subscription status. Full data available on IPOMatrix.com.
| Category | Subscription (times) | Shares Offered | Shares bid for | |
|---|---|---|---|---|
| Total | 15.50 | 38,70,000 | 5,99,93,730 | |
| Price Details | NSE | BSE |
|---|---|---|
| Final Issue Price | ₹240.00 | ₹240.00 |
| Open | ₹300.00 | ₹298.90 |
| Low | ₹254.10 | ₹253.00 |
| High | ₹309.95 | ₹303.00 |
| Last Trade | ₹260.10 | ₹259.55 |
Lead Manager Reports
Nectar Lifesciences IPO is a main-board IPO of 38,70,000 equity shares of the face value of ₹10 aggregating up to ₹93 Crores. The issue is priced at ₹240 per share. The minimum order quantity is .
The IPO opens on Wed, Jun 22, 2005, and closes on Tue, Jun 28, 2005.
Kfin Technologies Ltd. is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
Zerodha customers can apply online in Nectar Lifesciences IPO using UPI as a payment gateway. Zerodha customers can apply in Nectar Lifesciences IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Nectar Lifesciences IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Nectar Lifesciences IPO opens on Wed, Jun 22, 2005 and closes on Tue, Jun 28, 2005.
Nectar Lifesciences IPO lot size and the minimum order quantity is not available at this time. Please check again later.
You can apply in Nectar Lifesciences IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Nectar Lifesciences IPO will be done on [.], and the allotted shares will be credited to your demat account by . Check the Nectar Lifesciences IPO allotment status.
The Nectar Lifesciences IPO listing date is on .
